Nevertheless, subgroup analysis revealed no significant prognostic differences between patients with and without SS (Table S3), indicating that SS itself does not explain the elevated risk associated with isolated anti‐SSA seropositivity. Here, TRIM21 is linked to synovial sarcoma.